AxoGen logo

AxoGen

AXGN | NASDAQ
Chart Builder DCF Calculator
$55.38
-$0.55 (-0.98%)
At close: Nov 16, 2026, 4:00 PM ET
$55.10
-$0.28 (-0.51%)
After-hours: Nov 16, 2026, 7:44 PM ET
-0.98%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52.7
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #222/1021 (Top 22%)

Key Statistics

Market Data

Market Cap $3.31B
1D Range
55.00 56.35
52W Range
23.57 58.63

Valuation (TTM)

PE -85.20
PB 6.67
EV/EBITDA -140.27

Valuation (NTM)

Forward PE 101.69
Forward PEG -1.08
Price Target $57.50
Loading financial charts...

Profile

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfol...

Sector Healthcare
Employees 622
IPO Date Dec 17, 1986
Fiscal Year January - December

Latest News

AxoGen: 3 Key Takeaways for Long-Term Investors

9 hours ago · fool.com

AxoGen: 3 Key Takeaways for Long-Term Investors
AxoGen (AXGN) is a Great Momentum Stock: Should You Buy?

4 days ago · zacks.com

AxoGen (AXGN) is a Great Momentum Stock: Should You Buy?
Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development Transcript

7 days ago · seekingalpha.com

Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development Transcript
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

14 days ago · globenewswire.com

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Axogen: Taking The Friction Out Of Nerve Repair

18 days ago · seekingalpha.com

Axogen: Taking The Friction Out Of Nerve Repair
Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?

19 days ago · zacks.com

Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?
AxoGen Q3 Earnings Call Highlights

19 days ago · marketbeat.com

AxoGen Q3 Earnings Call Highlights
Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript

20 days ago · seekingalpha.com

Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript
AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates

20 days ago · zacks.com

AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates
Axogen, Inc. Reports Third Quarter 2026 Financial Results

20 days ago · globenewswire.com

Axogen, Inc. Reports Third Quarter 2026 Financial Results

Earnings

Latest Earnings
Oct 28, 2026
EPS
$0.21
Beat +59.94%
REV
$75.83M
Beat +3.24%
Next Earnings
Feb 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
10
Consensus
Buy
Price Target
$57.50
Upside
+3.83%
Buy (10)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.